BioCentury
ARTICLE | Politics, Policy & Law

Ramping up for drug surveillance

May 16, 2005 7:00 AM UTC

CMS plans to use its clout as the world's largest healthcare financing agency and its imminent emergence as the biggest single payer for prescription drugs to collect post-market safety and efficacy data.

Along with the new Part D prescription drug program, CMS is rolling out a Coordination of Benefits system in January 2006 that will link payers to drug purchasing information at the point of sale. It will create a complete claims history for every beneficiary, including data on primary and secondary claims (e.g., both Medicare and private insurance)...